Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-23-017885

Options or other derivatives

  • Chief Medical Officer acquired 87,495 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Obrocea Mihail Chief Medical Officer 2023-05-31 Grant or award · Stock Options +87,495 87,495 D: show line 1 in the form
Loading xslF345X04/form4.xml…